Woodmont Investment Counsel LLC Raises Stock Holdings in HCA Healthcare Inc (NYSE:HCA)
Woodmont Investment Counsel LLC increased its position in HCA Healthcare Inc (NYSE:HCA) by 0.9% during the 2nd quarter, Holdings Channel.com reports. The firm owned 43,695 shares of the company’s stock after purchasing an additional 382 shares during the period. HCA Healthcare comprises 1.5% of Woodmont Investment Counsel LLC’s investment portfolio, making the stock its 16th largest position. Woodmont Investment Counsel LLC’s holdings in HCA Healthcare were worth $5,906,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently modified their holdings of the stock. Westside Investment Management Inc. purchased a new stake in shares of HCA Healthcare in the second quarter worth $34,000. NEXT Financial Group Inc purchased a new stake in shares of HCA Healthcare in the second quarter worth $43,000. Rational Advisors LLC grew its stake in shares of HCA Healthcare by 5,118.2% in the first quarter. Rational Advisors LLC now owns 574 shares of the company’s stock worth $75,000 after acquiring an additional 563 shares during the last quarter. Cornerstone Advisors Inc. grew its stake in shares of HCA Healthcare by 19.6% in the first quarter. Cornerstone Advisors Inc. now owns 587 shares of the company’s stock worth $77,000 after acquiring an additional 96 shares during the last quarter. Finally, Alpha Windward LLC grew its stake in shares of HCA Healthcare by 50.9% in the second quarter. Alpha Windward LLC now owns 608 shares of the company’s stock worth $89,000 after acquiring an additional 205 shares during the last quarter. 70.19% of the stock is currently owned by institutional investors.
In other HCA Healthcare news, SVP Kathleen M. Whalen sold 977 shares of the stock in a transaction dated Tuesday, August 13th. The stock was sold at an average price of $127.56, for a total value of $124,626.12. Following the transaction, the senior vice president now owns 11,484 shares of the company’s stock, valued at $1,464,899.04. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, SVP Robert A. Waterman sold 33,786 shares of the stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $134.98, for a total value of $4,560,434.28. Following the completion of the transaction, the senior vice president now directly owns 279,551 shares in the company, valued at approximately $37,733,793.98. The disclosure for this sale can be found here. 2.70% of the stock is currently owned by corporate insiders.
HCA Healthcare (NYSE:HCA) last posted its earnings results on Tuesday, July 30th. The company reported $2.21 earnings per share for the quarter, missing analysts’ consensus estimates of $2.49 by ($0.28). HCA Healthcare had a net margin of 7.46% and a negative return on equity of 135.90%. The firm had revenue of $12.60 billion during the quarter, compared to the consensus estimate of $12.61 billion. During the same period in the prior year, the company posted $2.29 EPS. The firm’s revenue was up 9.3% compared to the same quarter last year. Equities research analysts anticipate that HCA Healthcare Inc will post 10.4 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Tuesday, September 3rd will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 1.28%. The ex-dividend date of this dividend is Friday, August 30th. HCA Healthcare’s dividend payout ratio is 16.38%.
HCA has been the topic of a number of recent research reports. ValuEngine cut HCA Healthcare from a “hold” rating to a “sell” rating in a research note on Tuesday. Mizuho set a $153.00 target price on HCA Healthcare and gave the stock a “buy” rating in a research note on Wednesday, July 31st. Stephens set a $150.00 target price on HCA Healthcare and gave the stock a “buy” rating in a research note on Wednesday, August 7th. Goldman Sachs Group raised HCA Healthcare from a “neutral” rating to a “buy” rating and increased their target price for the stock from $147.00 to $160.00 in a research note on Wednesday, July 10th. Finally, Zacks Investment Research cut HCA Healthcare from a “buy” rating to a “hold” rating and set a $130.00 target price on the stock. in a research note on Monday, May 27th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and fifteen have given a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $155.29.
HCA Healthcare Profile
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Recommended Story: How is a buy-side analyst different from a sell-side analyst?
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.